WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Stock

$1.53+0.02 (+1.32%)
Updated Jun 2, 2023
CADL Price
$1.53
Fair Value Price
N/A
Market Cap
$44.25M
52 Week Low
$1.15
52 Week High
$4.25
P/E
-1.68x
P/B
1.12x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$26.72M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.7
Operating Cash Flow
-$34M
Beta
1.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CADL Overview

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing immunotherapies for cancer patients. Its pipeline includes CAN-2409, in Phase II clinical trials for the treatment of pancreatic cancer, Phase III clinical trials for the treatment of prostate cancer, Phase II clinical trials for the treatment of lung cancer, and Phase Ib/II clinical trials (completed) for the treatment of high-grade glioma. The company is also developing CAN-3110, in Phase I clinical trials for the treatment of recurrent glioblastoma. Candel Therapeutics was incorporated in 2003 and is based in Needham, MA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CADL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CADL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CADL is good value based on its book value relative to its share price (1.12x), compared to the US Biotechnology industry average (5.2x)
P/B vs Industry Valuation
CADL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CADL due diligence checks available for Premium users.

Be the first to know about important CADL news, forecast changes, insider trades & much more!

CADL News

Valuation

CADL fair value

Fair Value of CADL stock based on Discounted Cash Flow (DCF)
Price
$1.53
Fair Value
$4.67
Undervalued by
67.25%
CADL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CADL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.68x
Industry
11.51x
Market
52.69x

CADL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.12x
Industry
5.2x
CADL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CADL's financial health

Profit margin

Revenue
$0.0
Net Income
-$8.8M
Profit Margin
0%
CADL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$67.2M
Liabilities
$27.6M
Debt to equity
0.7
CADL's short-term assets ($61.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CADL's short-term assets ($61.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CADL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.8M
Investing
$19.0k
Financing
$0.0
CADL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CADL vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CADL$44.25M+1.32%-1.68x1.12x
NCNA$44.01M-1.18%-1.12x1.11x
GRNA$44.59M+1.38%-0.26x2.03x
SNSE$43.68M-3.42%-0.93x0.46x
ELDN$43.44M-2.03%-0.31x0.58x

Candel Therapeutics Stock FAQ

What is Candel Therapeutics's quote symbol?

(NASDAQ: CADL) Candel Therapeutics trades on the NASDAQ under the ticker symbol CADL. Candel Therapeutics stock quotes can also be displayed as NASDAQ: CADL.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.

What is the 52 week high and low for Candel Therapeutics (NASDAQ: CADL)?

(NASDAQ: CADL) Candel Therapeutics's 52-week high was $4.25, and its 52-week low was $1.15. It is currently -64% from its 52-week high and 33.04% from its 52-week low.

How much is Candel Therapeutics stock worth today?

(NASDAQ: CADL) Candel Therapeutics currently has 28,919,810 outstanding shares. With Candel Therapeutics stock trading at $1.53 per share, the total value of Candel Therapeutics stock (market capitalization) is $44.25M.

Candel Therapeutics stock was originally listed at a price of $7.00 in Jul 27, 2021. If you had invested in Candel Therapeutics stock at $7.00, your return over the last 1 years would have been -78.14%, for an annualized return of -78.14% (not including any dividends or dividend reinvestments).

How much is Candel Therapeutics's stock price per share?

(NASDAQ: CADL) Candel Therapeutics stock price per share is $1.53 today (as of Jun 2, 2023).

What is Candel Therapeutics's Market Cap?

(NASDAQ: CADL) Candel Therapeutics's market cap is $44.25M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Candel Therapeutics's market cap is calculated by multiplying CADL's current stock price of $1.53 by CADL's total outstanding shares of 28,919,810.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.